W81K00-23-Q-0124 - Solicitation, Amendment 0001 - Human Papillomavirus High Risk Testing, Detection, and Genotyping (genotypes 16 & 18) for the Brooke Army Medical Center (BAMC), Fort Sam Houston, Texas.

This solicitation seeks proposals to provide human papillomavirus (HPV) high-risk testing, detection, and genotyping services for the Brooke Army Medical Center in Fort Sam Houston, Texas. The Department of the Army Medical Command will award a single contract for a base year starting October 2023 with four optional one-year extensions. Proposals are due by July 28, 2023 with award by September 30, 2023. The contractor must supply two new automated analyzers that can process 376-400 samples per day, FDA-approved reagents for HPV DNA amplification/detection testing of 80,000 samples annually, and genotyping for HPV 16 and 18. The equipment must integrate with the MHS Genesis electronic health record.

There is no set-aside designation. The contractor is responsible for installation, training, preventative maintenance, repairs, and removing the equipment at the end of the contract term. Pricing will be based on a cost-per-test arrangement. The place of performance is San Antonio, Texas. The solicitation seeks to award a contract by September 30, 2023 to provide these services for the base year starting in October 2023 at the Brooke Army Medical Center located at Fort Sam Houston, Texas.